Field experiments to evaluate the feasibility of eradication of Aujeszky's disease virus by different vaccination schedules. 1992

K De Smet, and K De Waele, and M Pensaert, and D Goovaerts, and E De Ridder
Laboratory of Virology and Immunology, Faculty of Veterinary Medicine, State University of Gent, Belgium.

In the present report, the extent of the reduction in Aujeszky's disease virus (ADV) dissemination achieved when pigs were intensively vaccinated with gI-deleted vaccines under field circumstances, was examined. On widely dispersed breeding-fattening farms, a gI-negative status was most rapidly obtained and the rate of new waves of infections was lowest when the attenuated Bartha strain was administered to both the sows and the fatteners. It was more difficult not only to reach but also to keep a gI-negative status on farms on which the sows were vaccinated with an inactivated vaccine and the fatteners with the attenuated Bartha strain or when the fattening pigs were not vaccinated at all. In a densely populated area, 9 of the 17 farms had gI-positive fatteners at the start of the intensive vaccination programme in which the attenuated Bartha strain was given to both the sows and the fatteners. Antibodies were not detected in the sera of the fatteners of each farm at some time during the experiments, but the fatteners on 7 of the 18 farms still showed antibodies against gI after 20 months of vaccination. At the end of the experiment, the percentage of fatteners with antibodies on these farms was markedly reduced compared with the percentage at the start of the experiment. Therefore, elimination of field virus may be feasible if intensive vaccination is carried out over a sufficiently long period of time. However, the high rate of reinfections experienced either due to reintroduction of the virus or to recrudescence should be a warning against too much optimism, particularly in regions with a dense swine population.

UI MeSH Term Description Entries
D008297 Male Males
D011557 Pseudorabies A highly contagious herpesvirus infection affecting the central nervous system of swine, cattle, dogs, cats, rats, and other animals. Aujeszky's Disease,Aujeszky Disease,Aujeszkys Disease
D011558 Herpesvirus 1, Suid A species of VARICELLOVIRUS producing a respiratory infection (PSEUDORABIES) in swine, its natural host. It also produces an usually fatal ENCEPHALOMYELITIS in cattle, sheep, dogs, cats, foxes, and mink. Aujeszky's Disease Virus,Swine Herpesvirus 1,Aujeszky Disease Virus,Herpesvirus 1 (alpha), Suid,Herpesvirus Suis,Pseudorabies Virus,Suid Herpesvirus 1,Aujeszkys Disease Virus,Herpesvirus 1, Swine,Pseudorabies Viruses,Virus, Pseudorabies,Viruses, Pseudorabies
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D001530 Belgium A country in Western Europe, bordering the North Sea, between France and the Netherlands. The capital is Brussels.
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014613 Vaccines, Attenuated Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. Attenuated Vaccine,Vaccines, Live, Attenuated,Attenuated Vaccines,Vaccine, Attenuated

Related Publications

K De Smet, and K De Waele, and M Pensaert, and D Goovaerts, and E De Ridder
February 2004, Journal of veterinary medicine. B, Infectious diseases and veterinary public health,
K De Smet, and K De Waele, and M Pensaert, and D Goovaerts, and E De Ridder
October 1984, The Veterinary record,
K De Smet, and K De Waele, and M Pensaert, and D Goovaerts, and E De Ridder
January 1994, Acta veterinaria Hungarica,
K De Smet, and K De Waele, and M Pensaert, and D Goovaerts, and E De Ridder
April 1997, Veterinary microbiology,
K De Smet, and K De Waele, and M Pensaert, and D Goovaerts, and E De Ridder
July 1980, The Veterinary record,
K De Smet, and K De Waele, and M Pensaert, and D Goovaerts, and E De Ridder
February 1979, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B,
K De Smet, and K De Waele, and M Pensaert, and D Goovaerts, and E De Ridder
August 1994, The Veterinary record,
K De Smet, and K De Waele, and M Pensaert, and D Goovaerts, and E De Ridder
August 1984, The Veterinary record,
K De Smet, and K De Waele, and M Pensaert, and D Goovaerts, and E De Ridder
May 2013, Bulletin of mathematical biology,
K De Smet, and K De Waele, and M Pensaert, and D Goovaerts, and E De Ridder
June 2003, Journal of veterinary medicine. B, Infectious diseases and veterinary public health,
Copied contents to your clipboard!